SCOPUS 정보 검색 플랫폼

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 1076-1077

Unexpected serious adverse reactions to the therapy with botulinum toxin might be due to hypersensitivity

(1) Mezaki, Takahiro a

a Sakakibara Hakuho Hospital (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; AIRWAY OBSTRUCTION; BLEPHAROSPASM; CASE REPORT; CERVICAL DYSTONIA; CLINICAL PROTOCOL; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DYSARTHRIA; DYSPHAGIA; EYELID CLOSURE; FEEDING DISORDER; FEMALE; HEAVY-HEADEDNESS; HUMAN; LAGOPHTHALMOS; LETTER; MALE; OROMANDIBULAR DYSTONIA; PRIORITY JOURNAL; SPEECH DISORDER;

AGED; BOTULINUM TOXINS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 70449713392 PISSN: 03069877 EISSN: None Source Type: Journal
DOI: 10.1016/j.mehy.2009.07.034 Document Type: Letter

Times cited : (2)

References (7)

1
- 0031450649
- Botulinum toxin type A: from toxin to therapeutic agent
- Aoki K.R., Ismail M., Tang-Liu D., Brar B., and Wheeler L.A. Botulinum toxin type A: from toxin to therapeutic agent. Eur J Neurol 4 Suppl. 2 (1997) S1-S3
- (1997) Eur J Neurol , vol.4 , Issue.SUPPL. 2
- Aoki, K.R.¹ Ismail, M.² Tang-Liu, D.³ Brar, B.⁴ Wheeler, L.A.⁵

2
- 33745379807
- Treatment of cerebral palsy with botulinum toxin
- Bonn
- Berweck S, Heinen F. Treatment of cerebral palsy with botulinum toxin. Principles, Clinical Practice, Atlas, Child&Brain, Bonn, 2003.
- (2003) Principles, Clinical Practice, Atlas, Child&Brain
- Berweck, S.¹ Heinen, F.²

3
- 0024194826
- Systemic toxicity of botulinum toxin by intramuscular injection in the monkey
- Scott A.B., and Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 3 (1988) 333-335
- (1988) Mov Disord , vol.3 , pp. 333-335
- Scott, A.B.¹ Suzuki, D.²

4
- 35648944341
- High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy
- Willis A.W., Crowner B., Brunstrom J.E., Kissel A., and Racette B.A. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Dev Med Child Neurol 49 (2007) 818-822
- (2007) Dev Med Child Neurol , vol.49 , pp. 818-822
- Willis, A.W.¹ Crowner, B.² Brunstrom, J.E.³ Kissel, A.⁴ Racette, B.A.⁵

5
- 0031057980
- Generalized botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases
- Bakheit A.M.O., Ward C.D., and McLellan D.L. Generalized botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry 62 (1997) 198
- (1997) J Neurol Neurosurg Psychiatry , vol.62 , pp. 198
- Bakheit, A.M.O.¹ Ward, C.D.² McLellan, D.L.³

6
- 0032997550
- Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases
- Bhatia K.P., Münchau A., Thompson P.D., et al. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases. J Neurol Neurosurg Psychiatry 67 (1999) 90-93
- (1999) J Neurol Neurosurg Psychiatry , vol.67 , pp. 90-93
- Bhatia, K.P.¹ Münchau, A.² Thompson, P.D.³

7
- 0036845928
- Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity
- Wyndaele J.J., and van Dromme S.A. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40 (2002) 599-600
- (2002) Spinal Cord , vol.40 , pp. 599-600
- Wyndaele, J.J.¹ van Dromme, S.A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.